Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 141Neoplasms 114Prostatic Neoplasms 59Lung Neoplasms 57Colorectal Neoplasms 52Motor Activity 34Pancreatic Neoplasms 28Uterine Cervical Neoplasms 24Carcinoma, Non-Small-Cell Lung 22Brain Neoplasms 20Head and Neck Neoplasms 19Carcinoma, Hepatocellular 19Rectal Neoplasms 18Ovarian Neoplasms 18Anxiety Disorders 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Disease 15Depression 15Colonic Neoplasms 15Stomach Neoplasms 14Melanoma 14Hematologic Neoplasms 12Lymphoma, Follicular 11Glioblastoma 11Urinary Bladder Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Smoking Cessation 10Papillomavirus Infections 10Liver Neoplasms 10Leukemia, Myeloid, Acute 10

Interventions

Standard of Care 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × ACT-GEN × 30 days × Clear all
NCT07565467 2026-05-04

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
80 enrolled

ACT-GEN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡